COFCO Biotechnology Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 18,056.51 million compared to CNY 13,985.11 million a year ago. Revenue was CNY 18,056.51 million compared to CNY 13,985.11 million a year ago. Net income was CNY 940.84 million compared to CNY 533.75 million a year ago. Basic earnings per share from continuing operations was CNY 0.5086 compared to CNY 0.2887 a year ago. Diluted earnings per share from continuing operations was CNY 0.5072 compared to CNY 0.2883 a year ago.